eLife (Jul 2023)

Inhibition of DNMT1 methyltransferase activity via glucose-regulated O-GlcNAcylation alters the epigenome

  • Heon Shin,
  • Amy Leung,
  • Kevin R Costello,
  • Parijat Senapati,
  • Hiroyuki Kato,
  • Roger E Moore,
  • Michael Lee,
  • Dimitri Lin,
  • Xiaofang Tang,
  • Patrick Pirrotte,
  • Zhen Bouman Chen,
  • Dustin E Schones

DOI
https://doi.org/10.7554/eLife.85595
Journal volume & issue
Vol. 12

Abstract

Read online

The DNA methyltransferase activity of DNMT1 is vital for genomic maintenance of DNA methylation. We report here that DNMT1 function is regulated by O-GlcNAcylation, a protein modification that is sensitive to glucose levels, and that elevated O-GlcNAcylation of DNMT1 from high glucose environment leads to alterations to the epigenome. Using mass spectrometry and complementary alanine mutation experiments, we identified S878 as the major residue that is O-GlcNAcylated on human DNMT1. Functional studies in human and mouse cells further revealed that O-GlcNAcylation of DNMT1-S878 results in an inhibition of methyltransferase activity, resulting in a general loss of DNA methylation that preferentially occurs at partially methylated domains (PMDs). This loss of methylation corresponds with an increase in DNA damage and apoptosis. These results establish O-GlcNAcylation of DNMT1 as a mechanism through which the epigenome is regulated by glucose metabolism and implicates a role for glycosylation of DNMT1 in metabolic diseases characterized by hyperglycemia.

Keywords